Doctors Call Moderna-Merck Melanoma Vaccine Trial Results Meaningful

3 outlets reporting

Your call?🐂 Bullish🐻 Bearish

42%

lower recurrence risk

The combination lowered the hazard of recurrence or death by 42% in a 1,137-patient trial, but an overall-survival benefit has not been established.